載入...
BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma
Approximately, 50% of human melanomas are driven by BRAF mutations, which produce tumors that are highly immunosuppressive and often resistant to vaccine therapy. We introduced lipid-coated calcium phosphate nanoparticles (LCP NPs) as a carrier to efficiently deliver a tumor-specific antigen, the BR...
Na minha lista:
| 發表在: | Cancer Immunol Immunother |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer Berlin Heidelberg
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5801101/ https://ncbi.nlm.nih.gov/pubmed/29094184 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-017-2079-7 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|